American Conference Institute’s 8th Annual Paragraph IV Disputes
Now in its eighth iteration, American Conference Institute's (ACI's) Paragraph IV Disputes conference is the only event which helps both brand name and generic pharmaceutical companies make sense of changing industry dynamics precipitated by the patent cliff and other factors such as patent reform, regulatory shifts and recent and pending case law. This is the conference that not only sets the standards for Paragraph IV litigation, but also serves as the annual meeting place for the “who's who” of pharmaceutical patent litigation.
WilmerHale Partner Christopher Noyes will speak on the panel “Use of IPR and Other PTO Proceedings in A Paragraph IV Challenge: Strategies For Brand Names and Generics in Navigating PTO Proceedings in ANDA Litigation.”
